The report "Transplant Diagnostics Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Browse 79 market data Tables and 60 Figures spread through 180 Pages and in-depth TOC on "Transplant Diagnostics Market
http://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.html
Early buyers will receive 10% customization on reports.
Download PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=96374742
On basis of technology, the transplant diagnostics market is categorized into molecular assay technology [including PCR-based (Sequence-specific oligonucleotide and sequence-specific primer-PCR) and sequencing-based (next-generation sequencing and Sanger sequencing)] and non-molecular assay technology (includes serological and mixed lymphocyte culture assays). The molecular assay segment is expected to account for the larger share of the global transplant diagnostics market in 2016.
Factors such as growing number of solid organ, soft tissue, and stem cell transplantations; technological advancements; and increased funding, research grants, and public-private investments are the key market drivers for the transplant diagnostics industry. However, high device costs associated with NGS and PCR-based devices and limited medical reimbursements for organ donation and transplantation procedure restrain the growth of the market to a certain extent.
Inquiry of this report @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=96374742
As of 2015, the key players in the transplant diagnostics market included Thermo Fischer Scientific, Inc. (U.S.), Immucor, Inc. (U.S), Olerup SSp AB (Sweden), QIAGEN, Inc. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), Affymetrix, Inc. (U.S.), Illumina Inc. (U.S.), Luminex Corporation, (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Abbott Laboratories, Inc. (U.S.), among others.